Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Research ArticleArticle

The Importance of Colorectal Cancer Screening

David E. Beck
Ochsner Journal March 2012, 12 (1) 7-8;
David E. Beck
Chairman, Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

March is National Colorectal Cancer Awareness Month. This designation is important because an estimated 103,170 cases of colon cancer and 40,290 cases of rectal cancer are expected to occur in 2012.1 A total of 51,690 deaths from colorectal cancer are estimated for 2012, accounting for almost 10% of all cancer deaths. While colorectal cancer is the third most common cancer in both men and women, incidence rates have been decreasing for the past 2 decades. Consequently, mortality rates from colorectal cancer have also declined in both men and women, reflecting the declining incidence rates and improvements in early detection and treatment.

As physicians, we know that colorectal cancer is a disease for which screening is appropriate. Unfortunately, screening rates are not adequate to eliminate this important cancer. Even physicians and their families are not uniformly screened. Several factors may explain this failure.

Colonoscopy is the gold standard screening method for colorectal cancer. A major issue with the procedure has been the required bowel preparation. We currently have several methods to clean the colon prior to a colonoscopy2: (1) the traditional lavage preparation (GoLYTELY, NuLYTELY, TriLyte, etc), (2) a low-volume lavage preparation (HalfLytely, MiraLAX, etc), and (3) sodium phosphate in a tablet form. Each of these methods has advantages and limitations, but we can usually select an acceptable method. Additional information on colonoscopy and bowel preparation is available on the Ochsner website at www.ochsner.org/CRS.

Economics is often an issue. In addition to the challenging economy, the newer catastrophic or high-deductible health plans, as well as copay issues, have limited screening. In this cost-conscious environment, we must critically analyze our recommendations. Screening has been shown to be cheaper than treating colorectal cancer if compliance rates are high and the cost of screening tests is reasonable.3 In perspective, the health advantages of screening should certainly outweigh the equivalent of several months of cable television. Current recommendations for screening for colorectal cancer range from annual fecal occult blood testing with flexible sigmoidoscopy at 3- to 5-year intervals to colonoscopy at 10-year intervals starting at age 50 for average risk individuals. These screening methods have all shown reduced mortality.4-6 Because colonoscopy views the entire colon and can treat polyps, it is the preferred method, and Medicare began reimbursement for screening colonoscopy in 2001. Another option, available at Ochsner, is computed tomography colography. Studies have shown reasonable accuracy in detecting significant lesions, but bowel preparation is still currently required, availability of the test is limited, and reimbursement issues have not been resolved. Currently, this option is best for patients with coagulation issues or a technical inability to have a complete colonoscopy.

On the national and local levels, multiple efforts are underway to expand colorectal screening. Groups such as Coaches Against Cancer, television programs, radio spots, print articles, and local lectures contribute, but physician encouragement of screening must become a daily component of our patient care. Upgrades to electronic medical records provide timely reminders on screening status. We must also lead by example and ensure that each of us, as well as our family members at risk, gets screened. Progress is occurring, but each of us needs to continue and to increase our efforts to expand screening until it becomes universal. Remember, the recommendation and example of a trusted physician are major determinants of patient action.

Additional information is available from any of our colon and rectal surgeons or gastroenterologists and the Ochsner website (www.ochsner.org). Open access colonoscopies can be scheduled by calling one of the Ochsner endoscopy scheduling nurses at (504) 842-4060. Saturday appointments are available to minimize the impact on patients' daily schedules.

  • Academic Division of Ochsner Clinic Foundation

REFERENCES

  1. 1.↵
    1. American Cancer Society
    What are the key statistics about colorectal cancer. http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-key-statistics. Accessed January 25, 2012.
  2. 2.↵
    1. Wexner SD,
    2. Beck DE,
    3. Baron TH,
    4. et al.
    (2006 Jun) A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society of Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 63(7):894–909, pmid:16733101.
    OpenUrlPubMed
  3. 3.↵
    1. Winawer SJ,
    2. Zauber AAG,
    3. Ho MN,
    4. et al.
    (1993 Dec 30) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329(27):1977–1981, pmid:8247072.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Mandel JS,
    2. Bond JH,
    3. Church TR,
    4. et al.
    (1993 May 13) Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328(19):1365–1371, pmid:8474513.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Selby JV,
    2. Friedeman GD,
    3. Quesenberry CP,
    4. et al.
    (1992 Mar 5) A case-controlled study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657, pmid:1736103.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Newcomb PA,
    2. Norfleet RG,
    3. Storer BE,
    4. Surawicz TS,
    5. Marcus PM
    (1992 Oct 21) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572–1575, pmid:1404450.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 12, Issue 1
Mar 2012
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Importance of Colorectal Cancer Screening
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Importance of Colorectal Cancer Screening
David E. Beck
Ochsner Journal Mar 2012, 12 (1) 7-8;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Importance of Colorectal Cancer Screening
David E. Beck
Ochsner Journal Mar 2012, 12 (1) 7-8;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • REFERENCES
  • References
  • Info & Metrics
  • PDF

Cited By...

  • Recent Publications by Ochsner Authors
  • Google Scholar

More in this TOC Section

  • From the Editor's Desk: A Focus on Organ Transplantation
  • Clinical Images: Interventional Management of Pediatric Rex Shunt Stenosis
  • Letters to the EditorBeware of Right Renal Vein Valves in Transplanted Kidneys: Renal Vein Valvuloplasty in a Donor KidneySeizure Caused by Tumor Necrosis Factor-Alpha Inhibitor-Induced Central Nervous System DemyelinationPositron Emission Tomography-Positive Pleural-Based Nodule Following Talc Pleurodesis
Show more Article

Similar Articles

Ochsner Journal Blog

Current Post

Be Careful Where You Publish

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire